Analysts expect Bio Green Med Solution, Inc. to report Q2 2026 revenue of approximately $0.82 million and an EPS loss of $0.05, with the stock currently trading at $0.91 against a conservative analyst target of $0.93. The primary focus for investors is the company's strategic pivot into sustainable medical waste management following its June 2026 agreement to acquire Future NRG Sdn. Bhd.
Since acquiring Fitters Sdn. Bhd. in late 2025, BGMS has successfully transitioned from biopharmaceutical research to fire safety protection, generating $0.8 million in initial product revenue last quarter. However, the company continues to face a major financial risk with a cash runway estimated at less than one year, making the scale-up of its new diversified segments critical for long-term viability.